Company Statement: Sandoz completes acquisition of EBEWE Pharma, improving global patient access to affordable injectable cancer medicines
Extract: Sandoz announced today that it has completed its USD 1.3 billion acquisition of EBEWE Pharma's specialty generic injectables business, paving the way for the creation of a global center of...To view the full article, register now.
Already a subscriber? Click here to view full article